US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III ...
» Should a pregnant patient be treated with radionuclides? » What should be done if radioiodine therapy is given to a patient who is later found to be pregnant? » Is there a risk to a pregnant woman ...
This international Delphi study, led by the European Society of Radiation Oncology as part of their Value-Based Radiation Oncology programme, brought together key experts from the radiation oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results